As of January 2026 ArriVent BioPharma has a market cap of NZ$1.57 Billion. This makes ArriVent BioPharma the world's 6130th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 20th, 2026 the market cap of ArriVent BioPharma was reported to be: